GeneFerm Biotechnology Co Ltd (1796) — Strategic Asset Allocation Index
GeneFerm Biotechnology Co Ltd (1796) has a Strategic Asset Allocation Index of 94.4% as of June 2023. Strategic assets (PP&E of NT$797.54 Million plus long-term investments of NT$-) total NT$797.54 Million, measured against net assets of NT$845.27 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
GeneFerm Biotechnology Co Ltd Strategic Asset Allocation Index (2017–2022)
This chart shows how GeneFerm Biotechnology Co Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of June 2023, the index stands at 94.4%, representing strategic assets of NT$797.54 Million against net assets of NT$845.27 Million TWD. Explore GeneFerm Biotechnology Co Ltd (1796) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for GeneFerm Biotechnology Co Ltd (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for GeneFerm Biotechnology Co Ltd from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 1796 stock market capitalisation.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 88.4% | NT$734.28 Million | NT$734.28 Million | NT$- | NT$830.77 Million | ▲ +20.1 pp |
| 2021 | 68.3% | NT$510.38 Million | NT$510.38 Million | NT$- | NT$747.66 Million | ▼ -38.1 pp |
| 2020 | 106.4% | NT$421.44 Million | NT$421.44 Million | NT$- | NT$396.19 Million | ▲ +65.9 pp |
| 2019 | 40.4% | NT$385.84 Million | NT$385.84 Million | NT$- | NT$954.50 Million | ▼ -23.4 pp |
| 2018 | 63.8% | NT$265.86 Million | NT$265.86 Million | NT$- | NT$416.51 Million | ▼ -20.4 pp |
| 2017 | 84.2% | NT$265.30 Million | NT$265.30 Million | NT$- | NT$314.95 Million | — |